New stromal cell treatment trial for chronic inflammatory diseases
People with chronic inflammatory diseases are taking part in a new cell therapy clinical trial that one participant said made them feel “miles better”.
The POLARISE trial, being organised by BHP f…
Treatment hope for patients with rare disorder following clinical trial
Patients with a rare hereditary disorder may soon benefit from a new treatment which has undergone a promising trial at Queen Elizabeth Hospital Birmingham (QEHB) – part of BHP founder-members Univer…
Center of Excellence Award Renewal for Allergy, Asthma and Immunology Center
The Allergy, Asthma, and Clinical Immunology Center in Birmingham has been successful in renewing its Center of Excellence status for another four-year term – re-affirming the Center’s international…
£12m research centre will improve efficiency of rare disease trials to unlock tests and treatments
Researchers from BHP founder member the University of Birmingham are part of a new £12m research centre to improve clinical trials for rare diseases.
The LifeArc Centre for Acceleration of Rare Di…
Midlands-Wales Advanced Therapy Treatment Centre part of £17.9m network renewal
The Advanced Therapy Treatment Centre network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by BHP founding members the University of Birmingham and University Hosp…
Launch of new international medical code for presymptomatic type 1 diabetes
Researchers at BHP founder-member the University of Birmingham have partnered with NHS England to produce a diagnostic code tailored for individuals in the early phases of type 1 diabetes, enhancing…